Participant
Agostino Ognibene, MD
Doc Ognibene Agostino graduated in medicine and surgery from the University of Florence where he also obtained a specialization in Biochemistry and Clinical Chemistry with a diagnostic focus. In 2008 he also obtained a 1st level Master in e-Medicine. During his career he has carried out numerous managerial activities until today where he is Director of the U.O.C. Clinical Chemical Analysis of the “Ospedali Riuniti dell'Aretino” hospital unit; Director of the Departmental Functional Area of Laboratory Medicine USL SUDEST and Director of the Department of Laboratory Medicine and Transfusional USL TUSCANY SOUTHEAST. As part of the research, he collaborates with the SOD of Forensic Medicine for the study of markers for calculating the time of death on the biological materials of cadavers (vitreous humor, urine). With the SOD of Endocrinology for the dosage of Vitamin B12 active in the seminal fluid in normal subjects and in obese subjects. He also works on the development of a method for the standardization of the reading of cellular elements in the Cephalorachidian Liquid.
Additional person involved in the project
Alessandro Pancrazi, MD
Dr. Pancrazzi is pecialized in Clinical Biochemistry, Quality Management System Auditor ISO9001.
Lab Manager for the activity of the Molecular Clinical Pathology sector - Analysis Laboratory, San Donato Hospital, Arezzo (Italy). From 2002 to 2009: working experiences at Careggi in the oncohematological study of chronic myeloproliferative from 2002 to 2019, collaborator in ministerial research studies and clinical trials. Membership of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology and member of the Study Group on Diagnostic applications of molecular biology clinic and Quality Assurance in Molecular Biology. Multi-year experience as a collaborator of the ELNet-WHO project for the standardization of diagnostic tests and coordinator of Italian JAKnet. Author and coauthor more fifty scientific publications in international journals such as Blood, American Journal of Pathology, British Journal of Haematology and others. Patent: gene mutation analysis system MPL515 by quantitative real-time PCR technique. Patent filed University of Florence, n. FI2007A000274, “Mutational analysis of chronic myeloproliferative diseases
Maria Lorubbio, MD
.........